India to Emerge As A Leading Vaccine Manufacturing Destination Finds RNCOS

NewswireToday - /newswire/ -
Noida, Uttar Pradesh, India, 2010/07/12 - Strong demand in the domestic market as well as an increase in exports will drive the growth of the Indian vaccine market, says RNCOS in its latest research study.

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

As per our new research report, “Global Vaccine Market Forecast to 2012”, the Indian vaccine market is growing superfluously with increasing health consciousness of the Indian population. Further, the product patent regime in the country has also prompted the global vaccine players to launch more products in the Indian market. Extensive research and profound analysis performed for the market together exhibited a high growth potential market for vaccines in the country. With strong demand in the domestic market as well as an increase in exports owing to an increase in demand from the WHO, GAVI and developing countries, it is anticipated that the Indian vaccine market will grow at a CAGR of over 20% during FY 2010- FY 2012.

We have done thorough research and prudent analysis of the global vaccine market and identified some critical factors that serve as a catalyst for the industry’s current and future growth outlook. The key benefits of vaccines such as a higher probability of R&D success and long product lifecycles with a negligible threat of generic substitution will pave the growth of the market in coming years by drawing more investments into the market. Based on some concrete market fundamentals, we anticipate that the Indian vaccine market will register one of the most impressive growths globally during our forecast period and will become one of the most dominating markets in the vaccines industry.

Our systematic and thorough research report studies the global vaccine market to give an insight into its various segments, including Therapeutics Vaccines, Influenza Vaccines, Adult/Travel vaccines, Basic Pediatric Vaccines, Proprietary Pediatric Vaccines, and Enhanced Pediatric Vaccines. The comprehensive analysis of the market has identified pediatric vaccines as currently the highest shareholder, but future will see a revival of the market when adult, therapeutic and influenza vaccine segments post a rapid growth.

“Global Vaccine Market Forecast to 2012” also provides information on the key competitors in the market along with their business information and areas of expertise. The report shows a highly concentrated structure of the market, with the top four players dominating the market. Also, it provides valuable information on recent M&A activity in the sector. The report provides information on both domestic and international companies. This will provide our clients a competitive edge over their competitors in the market.

Report/IM153

About RNCOS
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RNCOS E-Services (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.